• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Charles Saunders Outlines the Increasing Importance of Technology in Practices

Video

Practices increasingly need to use technology to deliver care in an increasingly value-based world, said Charles Saunders, MD, CEO of Integra Connect.

Practices increasingly need to use technology to deliver care in an increasingly value-based world, said Charles Saunders, MD, CEO of Integra Connect.

Transcript

Technology is increasingly important in delivery care—how are cancer practices benefiting from integrating technology into their practice?

Well, there are several elements of technology that are necessary in today’s post-MACRA [Medicare Access and CHIP Reauthorization Act], value-based world. The first of all is an electronic health record, which is a requirement of the Oncology Care Model. The second is technology to integrate data from a wide variety of sources, and to perform analysis of that data. Not only to measure either MIPS [Merit-based Incentive Payment System] or alternative payment model quality measures, but also to understand the drivers of cost and where there are opportunities to be more efficient and to save.

In addition, practices that are in the Oncology Care Model need to manage patients in between office visits to make sure that they avoid unnecessary emergency department visits, hospitalizations, and they engage in end-of-life, palliative care, and hospice care. So, having a care management platform and technology and to engage with patients is essential. And in cases where they are connecting clinical trials, they also need to have the ability to manage those trials and that generally means some type of clinical trials management system or ability to capture patient-entered data.

Related Videos
Shawn Kwatra, MD, dermatologist, John Hopkins University
Dr Laura Ferris Discusses Safety, Efficacy of JNJ-2113 in Patients with Plaque Psoriasis
dr krystyn van vliet
Martin Dahl, PhD, senior vice president, AnaptysBio
Jeff Stark, MD, vice president, head of medical immunology, UCB.
Jonathan Silverberg, MD, PhD, MPH, FAAD, professor of dermatology, director of clinical research and patch testing, George Washington University School of Medicine and Health Sciences
Monica Li, MD, University of British Columbia
Robert Sidbury, MD, MPH, FAAD, professor of pediatrics, division head of dermatology, Seattle Children's Hospital, University of Washington School of Medicine
Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University Chicago Medical School, founder and director of the Center for Medical Dermatology and Immunology Research
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.